| __timestamp | Lantheus Holdings, Inc. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 100244000 |
| Thursday, January 1, 2015 | 14358000 | 29674000 |
| Friday, January 1, 2016 | 12203000 | 14917000 |
| Sunday, January 1, 2017 | 18125000 | 14118000 |
| Monday, January 1, 2018 | 17071000 | 8737000 |
| Tuesday, January 1, 2019 | 20018000 | 6900000 |
| Wednesday, January 1, 2020 | 32788000 | 6248000 |
| Friday, January 1, 2021 | 44966000 | 12312000 |
| Saturday, January 1, 2022 | 311681000 | 19721000 |
| Sunday, January 1, 2023 | 77707000 | 31283000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, Lantheus Holdings, Inc. and MannKind Corporation have demonstrated contrasting R&D investment strategies. From 2014 to 2023, Lantheus Holdings increased its R&D spending by over 470%, peaking in 2022 with a staggering 311 million dollars. This surge underscores their commitment to pioneering advancements in medical imaging and diagnostics. Meanwhile, MannKind Corporation, known for its inhalable insulin products, has shown a more conservative approach, with R&D expenses fluctuating but generally declining by about 69% from their 2014 peak. This divergence highlights the varied strategies companies employ to navigate the competitive biotech landscape. As we look to the future, these trends offer a glimpse into how each company might continue to innovate and adapt in a rapidly changing industry.
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Jazz Pharmaceuticals plc vs MannKind Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs MannKind Corporation
R&D Insights: How PTC Therapeutics, Inc. and MannKind Corporation Allocate Funds
Research and Development Expenses Breakdown: Veracyte, Inc. vs MannKind Corporation